GlassScriptPhysician profile
Connor Grant Earls
NPI 1124796594
$577.88
in general payments reported to CMS, 2019-2025
17 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $73.61 · 2023: $163 · 2024: $98.30 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $119.45 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $79.52 | 2022-2023 | Gattex |
| Vertex Pharmaceuticals Incorporated | $58.95 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $39.78 | 2023-2025 | Keytruda, Keytruda Qlex |
| Smith+Nephew, INC. | $35.06 | 2023 | Stravix |
| Regeneron Healthcare Solutions, INC. | $31.56 | 2025 | Libtayo |
| Janssen Biotech, INC. | $27.40 | 2024 | Rybrevant |
| Jazz Pharmaceuticals INC. | $24.28 | 2025 | |
| Astellas Pharma US INC | $23.01 | 2025 | Xtandi |
| Davol INC. | $22.52 | 2025 | Arista |
| Braintree Laboratories, INC. | $20.43 | 2023 | Sutab |
| Kci USA, INC. | $19.47 | 2023 | Prevena, V.A.C. Veraflo |
| Lilly USA, LLC | $17.45 | 2025 | Jaypirca, Verzenio |
| Aveo Pharmaceuticals, INC. | $16.84 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $15.41 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $13.81 | 2023 | Savi Scout |
| Ambu INC. | $12.94 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connor Earls listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.